A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
Recruiting · NCT06844474 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC | non-small cell lung carcinoma | Recruiting | Phase 2 | 2026-09-08 | NCT06844474 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese People's Liberation Army (PLA) General Hospital | Beijing | China | 2 |